The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will present new safety and ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal ...

Union Budget 2026 | Investor attention is expected to turn to active pharmaceutical ingredient (API) makers, specialty drug ...

Lupin announced a strategic collaboration with TB Alliance, to advance the clinical development and commercialization of Telacebec for the treatment of mycobacterial diseases, such as tuberculosis (TB ...

Six pharmaceutical companies have applied to make a generic version of semaglutide, and competition will continue to heat up ...

India’s largest drug-maker Sun Pharmaceutical Industries posted a 16 per cent year-on-year (Y-o-Y) growth in its consolidated ...

Sun Pharmaceutical Industries Ltd on Friday reported its consolidated financial results for the third quarter ended December ...